Co-Diagnostics, Inc.
CODX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001692415
No open-market purchases or sales by Co-Diagnostics, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $1.85M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Co-Diagnostics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 39 | 44 | +5 |
| Shares | 4.36M | 4.64M | +282.3K (+6.5%) |
| Value | $4.89M | $5.81M | +$915.7K (+18.7%) |
New holders (8)
Institutions that held Co-Diagnostics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Koss-Olinger Consulting, LLC | 58,887 | $74.0K | 0.01% |
| Thompson Davis & Co., Inc. | 41,500 | $51.9K | 0.04% |
| Virtu Financial LLC | 27,909 | $35.0K | 0.00% |
| Wolverine Trading, LLC | 22,248 | $27.8K | 0.00% |
| PEAK6 Investments LLC | 19,803 | $24.8K | 0.00% |
| Two Sigma Securities, LLC | 17,598 | $22.0K | 0.00% |
| Bank of America Corp | 258 | $322 | 0.00% |
| Financial Network Wealth Advisors LLC | 100 | $125 | 0.00% |
Sold out (3)
Institutions that held Co-Diagnostics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| D. E. Shaw & Co., Inc. | 46,305 | $51.9K |
| XTX Topco Ltd | 23,625 | $26.5K |
| Man Group plc | 10,637 | $11.9K |